10 October – 12 October 2019
The DGK Heart Days brings together cardiologists
The DGK Heart Days brings together cardiologists, GPs, medical students, nurses, researchers, and various other healthcare professionals and provides the attendees with the opportunity to gain information relating to various aspects of cardiology and be a part of the discussions relating to the advances and issues of the heart-related diseases.
Acarix is a Swedish medical device company that innovates solutions for rapid AI-based rule out of Coronary Artery Disease (CAD). The CE approved and FDA DeNovo cleared Acarix CADScor®System is intended for patients experiencing chest pain with suspected CAD and designed to help reduce millions of unnecessary, invasive and costly diagnostic procedures. The CADScor system calculates a patient-specific CAD-score non-invasively in less than10 minutes and can help rule out more than one third of patients with at least 96% certainty of not being sick (in a population with approx. 10% CAD prevalence). Acarix is listed on the Nasdaq First North Premier Growth Market (ticker: ACARIX). Redeye AB (+46 (0)8 121 576 90, firstname.lastname@example.org) is Certified Advisor of Acarix.